RecruitingOBSERVATIONAL

CAPRI National Juvenile Idiopathic Arthritis Registry

This study, called the CAPRI National Juvenile Idiopathic Arthritis Registry, is collecting important information about children in Canada who have Juvenile Idiopathic Arthritis (JIA). JIA is a condition where a child's joints become inflamed, which can cause pain and stiffness. The researchers want to learn more about how JIA affects children over time, how different treatments work, and if there are any side effects. By gathering this ongoing data, doctors can make better decisions about care and discover new ways to treat JIA, helping to improve the lives of children and their families who are affected by this condition. It's a key step in understanding JIA better.

At a glance

Status

Recruiting

Sponsor

University of British Columbia

Enrolment target

1,238

Start

01 Feb 2017

Estimated completion

01 Feb 2026

Juvenile Idiopathic Arthritis (JIA)

What is this study about?

Juvenile Idiopathic Arthritis, or JIA, is a common type of arthritis that affects children under 16. It's when a child's immune system mistakenly attacks their own joints, causing pain, swelling, and stiffness. We don't fully understand why JIA happens, but it affects about 1 in every 1,000 children in Canada. If not treated properly, it can lead to lasting problems with movement and a child's overall well-being. This can affect the child, their family, and their daily life.

This study is being run by a group of expert children's rheumatologists across Canada, called CAPRI. They've been working together for 20 years, making big discoveries about JIA. The CAPRI JIA Registry is like an ongoing health record for Canadian children with JIA. They collect information over time about how the disease changes, how well treatments work, and any problems that might come up. This helps doctors learn more about JIA and find the best ways to care for children with the condition.

Even though there have been many studies, there are still a lot of questions. For example, families often want to know what the future holds for their child, which treatments are best, and what side effects to expect. This registry helps us answer these questions by collecting real-world information from many children. By understanding these patterns, doctors can make more informed decisions about treating JIA and helping children lead healthier, more active lives.

Key takeaways

It's a long-term study collecting information about children with JIA.
No new treatments or medications will be given; your child follows their usual care.
Helps doctors understand JIA better and improve future treatments for all children.
Your child must meet specific criteria regarding their JIA diagnosis or past study involvement.
Participation involves sharing medical information and completing questionnaires.
You can stop participating at any time without affecting your child's care.

Who may be eligible?

To join this study, a child must have been diagnosed with Juvenile Idiopathic Arthritis (JIA) within the last three months. We are also welcoming children who have previously taken part in two older studies called ReACCh-Out or LEAP, even if they were diagnosed longer ago, as long as they finished their two-year check-ups in the LEAP study.

Only children who have a confirmed diagnosis of JIA can take part. If a child was diagnosed with JIA more than three months ago and hasn't been part of the previous LEAP or ReACCh-Out studies, they won't be able to join. Also, if a family isn't able to answer questions in either English or French, they unfortunately won't be able to participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Is your child under 18 years old?
Was your child diagnosed with JIA within the last 3 months?
Did your child previously participate in the ReACCh-Out or LEAP studies?
Can you answer questions in English or French?
Does your child have a confirmed diagnosis of JIA?

Answer every question to see your result.

What does participation involve?

This study is a registry, which means it will collect information about your child's JIA over time. There won't be any new treatments or medications given as part of this study; your child will continue to receive their usual care from their doctor. You will be asked to complete questionnaires, likely about your child's health, how they are feeling, and their daily life. Researchers will also collect information from your child's medical records about their diagnosis, treatments, and any changes in their condition. The exact number of visits or the total time you'll be involved isn't specified, but as a registry, it's designed to follow children for an extended period to understand long-term effects.

Potential risks and benefits

The main benefit of taking part is contributing valuable information that can help doctors better understand JIA and improve care for all children with the condition in the future. There are no direct medical risks as no new treatments are being given. However, sharing personal health information always carries a small risk, though researchers will take steps to protect your child’s privacy. You are free to withdraw your child from the study at any time without needing to give a reason, and this will not affect your child's medical care in any way.

Locations (15)

University of Calgary / Alberta Children's Hospital
Verified postcode
Calgary, Canada· Recruiting
University of Alberta
Verified postcode
Edmonton, Canada· Recruiting
BC Children's Hospital
Verified postcode
Vancouver, Canada· Recruiting
University of Manitoba/Children's hospital research institute
Verified postcode
Winnipeg, Canada· Recruiting
Memorial University/Janeway Childrens Health and Rehabilitation Centre
Verified postcode
St. John's, Canada· Recruiting
IIWK Health Centre
Verified postcode
Halifax, Canada· Recruiting
McMaster University/McMaster Children's Hospital
Verified postcode
Hamilton, Canada· Recruiting
London Health Sciences Centre
Verified postcode
London, Canada· Recruiting
Children's Hospital of Eastern Ontario
Verified postcode
Ottawa, Canada· Recruiting
Hospital for Sick Children
Verified postcode
Toronto, Canada· Recruiting
McGill University Health Centre
Verified postcode
Montreal, Canada· Recruiting
Université de Montréal
Verified postcode
Montreal, Canada· Recruiting

Common questions

What is JIA?

JIA stands for Juvenile Idiopathic Arthritis. It's a type of arthritis in children where their joints become inflamed, causing pain and stiffness.

Will my child get a new medicine in this study?

No, this study is a registry, meaning it collects health information. Your child will continue with their usual JIA treatment as prescribed by their doctor.

Who is running this study?

This study is being run by the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI), a group of expert children's arthritis doctors across Canada.

How long will my child be in the study?

Because it's a registry, the study aims to collect information over a long period to understand how JIA changes over time. The exact duration isn't specified.

Will taking part affect my child's medical care?

No, your child's medical care will not be affected by their participation. You can also withdraw from the study at any time.

How to find out more

Jaime Guzman, MD, FRCPC

jguzman@cw.bc.ca 604-875-2437 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.